1 – 24 of 24
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Plasma p-tau181 and p-tau217 in discriminating PART, AD and other key neuropathologies in older adults
(
- Contribution to journal › Article
-
Mark
Amplification of the PLAG-family genes—PLAGL1 and PLAGL2—is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification
(
- Contribution to journal › Article
-
Mark
Genetical and epigenetical profiling identifies two subgroups of pineal parenchymal tumors of intermediate differentiation (PPTID) with distinct molecular, histological and clinical characteristics
(
- Contribution to journal › Article
-
Mark
Galectin-3 shapes toxic alpha-synuclein strains in Parkinson’s disease
(
- Contribution to journal › Article
- 2021
-
Mark
Integrated molecular and clinical analysis of low-grade gliomas in children with neurofibromatosis type 1 (NF1)
(
- Contribution to journal › Article
-
Mark
Early white matter pathology in the fornix of the limbic system in Huntington disease
(
- Contribution to journal › Article
-
Mark
PATZ1 fusions define a novel molecularly distinct neuroepithelial tumor entity with a broad histological spectrum
(
- Contribution to journal › Article
- 2020
-
Mark
[18F]Flortaucipir distinguishes Alzheimer’s disease from progressive supranuclear palsy pathology in a mixed-pathology case
(
- Contribution to journal › Letter
- 2019
-
Mark
TCF4 (E2-2) harbors tumor suppressive functions in SHH medulloblastoma
(
- Contribution to journal › Article
-
Mark
Novel tau fragments in cerebrospinal fluid : relation to tangle pathology and cognitive decline in Alzheimer’s disease
(
- Contribution to journal › Article
-
Mark
Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer’s disease
(
- Contribution to journal › Article
- 2018
-
Mark
Sex-specific genetic predictors of Alzheimer’s disease biomarkers
(
- Contribution to journal › Article
-
Mark
Synapsin III deficiency hampers α-synuclein aggregation, striatal synaptic damage and nigral cell loss in an AAV-based mouse model of Parkinson’s disease
(
- Contribution to journal › Article
- 2017
-
Mark
Tau neuropathology correlates with FDG-PET, but not AV-1451-PET, in progressive supranuclear palsy
(
- Contribution to journal › Article
-
Mark
Genome-wide, high-content siRNA screening identifies the Alzheimer’s genetic risk factor FERMT2 as a major modulator of APP metabolism
(
- Contribution to journal › Article
-
Mark
Genome-wide association study identifies four novel loci associated with Alzheimer’s endophenotypes and disease modifiers
(
- Contribution to journal › Article
-
Mark
Pathogenic implications of distinct patterns of iron and zinc in chronic MS lesions
(
- Contribution to journal › Article
- 2010
-
Mark
Intraneuronal β-amyloid accumulation and synapse pathology in Alzheimer's disease
(
- Contribution to journal › Scientific review
- 1996
-
Mark
Diminished neuronal damage in the rat brain by late treatment with the antipyretic drug dipyrone or cooling following cerebral ischemia
(
- Contribution to journal › Article
- 1994
-
Mark
Moderate hypothermia mitigates neuronal damage in the rat brain when initiated several hours following transient cerebral ischemia
(
- Contribution to journal › Article
- 1993
-
Mark
Initiation of protein synthesis and heat-shock protein-72 expression in the rat brain following severe insulin-induced hypoglycemia
(
- Contribution to journal › Article
- 1987
-
Mark
Protective effect of lesion to the glutamatergic cortico-striatal projections on the hypoglycemic nerve cell injury in rat striatum
(
- Contribution to journal › Article
- 1985
-
Mark
The dentate gyrus in hypoglycemia : Pathology implicating excititoxin-mediated neuronal necrosis
(
- Contribution to journal › Article
- 1984
-
Mark
The distribution of hypoglycemic brain damage
(
- Contribution to journal › Article